Selected research
Market Outlook & Growth Opportunities
Global Radiolabeled Compounds Synthesis Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Radiolabeled Compounds Synthesis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Radiolabeled Compounds Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Radiolabeled Compounds Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Radiolabeled Compounds Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Radiolabeled Compounds Synthesis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Radiolabeled Compounds Synthesis Service market include Eurofins, Revvity, Selcia, Labcorp, Pharmaron, WuXi AppTec, AM Chemicals, SEKISUI MEDICAL CO., LTD. and Nuvisan, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Radiolabeled Compounds Synthesis Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Radiolabeled Compounds Synthesis Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Radiolabeled Compounds Synthesis Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Radiolabeled Compounds Synthesis Service market.
Radiolabeled Compounds Synthesis Service Segment by Company
Eurofins
Revvity
Selcia
Labcorp
Pharmaron
WuXi AppTec
AM Chemicals
SEKISUI MEDICAL CO., LTD.
Nuvisan
Almac
Novandi Chemistry
Alfa Cytology
Institute of Isotopes Co. Ltd.
Headway
ViTrax
Radiolabeled Compounds Synthesis Service Segment by Type
Carbon-14 Radiosynthesis Services
Hydrogen-3 Radiosynthesis Services
Chiral Separation and Salt Formation
Others
Radiolabeled Compounds Synthesis Service Segment by Application
Medical Diagnosis and Treatment
Material Science
Nuclear Energy
Others
Radiolabeled Compounds Synthesis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Radiolabeled Compounds Synthesis Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Radiolabeled Compounds Synthesis Service key companies, revenue, market share, and recent developments.
3. To split the Radiolabeled Compounds Synthesis Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Radiolabeled Compounds Synthesis Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Radiolabeled Compounds Synthesis Service significant trends, drivers, influence factors in global and regions.
6. To analyze Radiolabeled Compounds Synthesis Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiolabeled Compounds Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiolabeled Compounds Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiolabeled Compounds Synthesis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radiolabeled Compounds Synthesis Service industry.
Chapter 3: Detailed analysis of Radiolabeled Compounds Synthesis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Radiolabeled Compounds Synthesis Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Radiolabeled Compounds Synthesis Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Radiolabeled Compounds Synthesis Service Industry Trends
Table 2. Radiolabeled Compounds Synthesis Service Industry Drivers
Table 3. Radiolabeled Compounds Synthesis Service Industry Opportunities and Challenges
Table 4. Radiolabeled Compounds Synthesis Service Industry Restraints
Table 5. Global Radiolabeled Compounds Synthesis Service Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Radiolabeled Compounds Synthesis Service Revenue Share by Company (2021-2026)
Table 7. Global Radiolabeled Compounds Synthesis Service Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Radiolabeled Compounds Synthesis Service Key Company Manufacturing Base & Headquarters
Table 9. Global Radiolabeled Compounds Synthesis Service Company, Product Type & Application
Table 10. Global Radiolabeled Compounds Synthesis Service Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Radiolabeled Compounds Synthesis Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Carbon-14 Radiosynthesis Services
Table 15. Significant Companies of Hydrogen-3 Radiosynthesis Services
Table 16. Significant Companies of Chiral Separation and Salt Formation
Table 17. Significant Companies of Others
Table 18. Global Radiolabeled Compounds Synthesis Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 19. Global Radiolabeled Compounds Synthesis Service Sales Value by Type (2021-2026) & (US$ Million)
Table 20. Global Radiolabeled Compounds Synthesis Service Sales Value by Type (2027-2032) & (US$ Million)
Table 21. Global Radiolabeled Compounds Synthesis Service Sales Value Share by Type (2021-2026)
Table 22. Global Radiolabeled Compounds Synthesis Service Sales Value Share by Type (2027-2032)
Table 23. Significant Companies of Medical Diagnosis and Treatment
Table 24. Significant Companies of Material Science
Table 25. Significant Companies of Nuclear Energy
Table 26. Significant Companies of Others
Table 27. Global Radiolabeled Compounds Synthesis Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 28. Global Radiolabeled Compounds Synthesis Service Sales Value by Application (2021-2026) & (US$ Million)
Table 29. Global Radiolabeled Compounds Synthesis Service Sales Value by Application (2027-2032) & (US$ Million)
Table 30. Global Radiolabeled Compounds Synthesis Service Sales Value Share by Application (2021-2026)
Table 31. Global Radiolabeled Compounds Synthesis Service Sales Value Share by Application (2027-2032)
Table 32. Global Radiolabeled Compounds Synthesis Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 33. Global Radiolabeled Compounds Synthesis Service Sales Value by Region (2021-2026) & (US$ Million)
Table 34. Global Radiolabeled Compounds Synthesis Service Sales Value Share by Region (2021-2026)
Table 35. Global Radiolabeled Compounds Synthesis Service Sales Value by Region (2027-2032) & (US$ Million)
Table 36. Global Radiolabeled Compounds Synthesis Service Sales Value Share by Region (2027-2032)
Table 37. Global Radiolabeled Compounds Synthesis Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 38. Global Radiolabeled Compounds Synthesis Service Sales Value by Country (2021-2026) & (US$ Million)
Table 39. Global Radiolabeled Compounds Synthesis Service Sales Value Market Share by Country (2021-2026)
Table 40. Global Radiolabeled Compounds Synthesis Service Sales Value by Country (2027-2032) & (US$ Million)
Table 41. Global Radiolabeled Compounds Synthesis Service Sales Value Market Share by Country (2027-2032)
Table 42. Eurofins Company Information
Table 43. Eurofins Business Overview
Table 44. Eurofins Radiolabeled Compounds Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 45. Eurofins Radiolabeled Compounds Synthesis Service Product Portfolio
Table 46. Eurofins Recent Development
Table 47. Revvity Company Information
Table 48. Revvity Business Overview
Table 49. Revvity Radiolabeled Compounds Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 50. Revvity Radiolabeled Compounds Synthesis Service Product Portfolio
Table 51. Revvity Recent Development
Table 52. Selcia Company Information
Table 53. Selcia Business Overview
Table 54. Selcia Radiolabeled Compounds Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 55. Selcia Radiolabeled Compounds Synthesis Service Product Portfolio
Table 56. Selcia Recent Development
Table 57. Labcorp Company Information
Table 58. Labcorp Business Overview
Table 59. Labcorp Radiolabeled Compounds Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 60. Labcorp Radiolabeled Compounds Synthesis Service Product Portfolio
Table 61. Labcorp Recent Development
Table 62. Pharmaron Company Information
Table 63. Pharmaron Business Overview
Table 64. Pharmaron Radiolabeled Compounds Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. Pharmaron Radiolabeled Compounds Synthesis Service Product Portfolio
Table 66. Pharmaron Recent Development
Table 67. WuXi AppTec Company Information
Table 68. WuXi AppTec Business Overview
Table 69. WuXi AppTec Radiolabeled Compounds Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 70. WuXi AppTec Radiolabeled Compounds Synthesis Service Product Portfolio
Table 71. WuXi AppTec Recent Development
Table 72. AM Chemicals Company Information
Table 73. AM Chemicals Business Overview
Table 74. AM Chemicals Radiolabeled Compounds Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 75. AM Chemicals Radiolabeled Compounds Synthesis Service Product Portfolio
Table 76. AM Chemicals Recent Development
Table 77. SEKISUI MEDICAL CO., LTD. Company Information
Table 78. SEKISUI MEDICAL CO., LTD. Business Overview
Table 79. SEKISUI MEDICAL CO., LTD. Radiolabeled Compounds Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. SEKISUI MEDICAL CO., LTD. Radiolabeled Compounds Synthesis Service Product Portfolio
Table 81. SEKISUI MEDICAL CO., LTD. Recent Development
Table 82. Nuvisan Company Information
Table 83. Nuvisan Business Overview
Table 84. Nuvisan Radiolabeled Compounds Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 85. Nuvisan Radiolabeled Compounds Synthesis Service Product Portfolio
Table 86. Nuvisan Recent Development
Table 87. Almac Company Information
Table 88. Almac Business Overview
Table 89. Almac Radiolabeled Compounds Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 90. Almac Radiolabeled Compounds Synthesis Service Product Portfolio
Table 91. Almac Recent Development
Table 92. Novandi Chemistry Company Information
Table 93. Novandi Chemistry Business Overview
Table 94. Novandi Chemistry Radiolabeled Compounds Synthesis Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Novandi Chemistry Radiolabeled Compounds Synthesis Service Product Portfolio
Table 96. Novandi Chemistry Recent Development
Table 97. Alfa Cytology Company Information
Table 98. Alfa Cytology Business Overview
Table 99. Alfa Cytology Radiolabeled Compounds Synthesis Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Alfa Cytology Radiolabeled Compounds Synthesis Service Product Portfolio
Table 101. Alfa Cytology Recent Development
Table 102. Institute of Isotopes Co. Ltd. Company Information
Table 103. Institute of Isotopes Co. Ltd. Business Overview
Table 104. Institute of Isotopes Co. Ltd. Radiolabeled Compounds Synthesis Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Institute of Isotopes Co. Ltd. Radiolabeled Compounds Synthesis Service Product Portfolio
Table 106. Institute of Isotopes Co. Ltd. Recent Development
Table 107. Headway Company Information
Table 108. Headway Business Overview
Table 109. Headway Radiolabeled Compounds Synthesis Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Headway Radiolabeled Compounds Synthesis Service Product Portfolio
Table 111. Headway Recent Development
Table 112. ViTrax Company Information
Table 113. ViTrax Business Overview
Table 114. ViTrax Radiolabeled Compounds Synthesis Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. ViTrax Radiolabeled Compounds Synthesis Service Product Portfolio
Table 116. ViTrax Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Authors List of This Report
Table 119. Secondary Sources
Table 120. Primary Sources
List of Figures
Figure 1. Radiolabeled Compounds Synthesis Service Product Image
Figure 2. Global Radiolabeled Compounds Synthesis Service Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Radiolabeled Compounds Synthesis Service Market Size (2021-2032) & (US$ Million)
Figure 4. Global Radiolabeled Compounds Synthesis Service Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Carbon-14 Radiosynthesis Services Image
Figure 8. Hydrogen-3 Radiosynthesis Services Image
Figure 9. Chiral Separation and Salt Formation Image
Figure 10. Others Image
Figure 11. Global Radiolabeled Compounds Synthesis Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 12. Global Radiolabeled Compounds Synthesis Service Sales Value Share 2021 VS 2025 VS 2032
Figure 13. Global Radiolabeled Compounds Synthesis Service Sales Value Share by Type (2021-2032)
Figure 14. Medical Diagnosis and Treatment Image
Figure 15. Material Science Image
Figure 16. Nuclear Energy Image
Figure 17. Others Image
Figure 18. Global Radiolabeled Compounds Synthesis Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 19. Global Radiolabeled Compounds Synthesis Service Sales Value Share 2021 VS 2025 VS 2032
Figure 20. Global Radiolabeled Compounds Synthesis Service Sales Value Share by Application (2021-2032)
Figure 21. Global Radiolabeled Compounds Synthesis Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 22. Global Radiolabeled Compounds Synthesis Service Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 23. North America Radiolabeled Compounds Synthesis Service Sales Value (2021-2032) & (US$ Million)
Figure 24. North America Radiolabeled Compounds Synthesis Service Sales Value Share by Country (%), 2025 VS 2032
Figure 25. Europe Radiolabeled Compounds Synthesis Service Sales Value (2021-2032) & (US$ Million)
Figure 26. Europe Radiolabeled Compounds Synthesis Service Sales Value Share by Country (%), 2025 VS 2032
Figure 27. Asia-Pacific Radiolabeled Compounds Synthesis Service Sales Value (2021-2032) & (US$ Million)
Figure 28. Asia-Pacific Radiolabeled Compounds Synthesis Service Sales Value Share by Country (%), 2025 VS 2032
Figure 29. South America Radiolabeled Compounds Synthesis Service Sales Value (2021-2032) & (US$ Million)
Figure 30. South America Radiolabeled Compounds Synthesis Service Sales Value Share by Country (%), 2025 VS 2032
Figure 31. Middle East & Africa Radiolabeled Compounds Synthesis Service Sales Value (2021-2032) & (US$ Million)
Figure 32. Middle East & Africa Radiolabeled Compounds Synthesis Service Sales Value Share by Country (%), 2025 VS 2032
Figure 33. USA Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 34. USA Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 35. USA Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 36. Canada Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 37. Canada Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 38. Canada Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 39. Mexico Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 40. Mexico Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 41. Mexico Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 42. Germany Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 43. Germany Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 44. Germany Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 45. France Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 46. France Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 47. France Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 48. U.K. Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 49. U.K. Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 50. U.K. Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 51. Italy Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 52. Italy Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 53. Italy Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 54. Spain Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 55. Spain Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 56. Spain Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 57. Russia Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 58. Russia Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 59. Russia Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 60. Netherlands Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 61. Netherlands Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 62. Netherlands Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 63. Nordic Countries Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 64. Nordic Countries Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 65. Nordic Countries Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 66. China Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 67. China Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 68. China Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 69. Japan Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 70. Japan Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 71. Japan Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 72. South Korea Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 73. South Korea Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 74. South Korea Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 75. India Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 76. India Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 77. India Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 78. Australia Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 79. Australia Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 80. Australia Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 81. Southeast Asia Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 82. Southeast Asia Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 83. Southeast Asia Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 84. Brazil Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 85. Brazil Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 86. Brazil Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 87. Argentina Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 88. Argentina Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 89. Argentina Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 90. Chile Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 91. Chile Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 92. Chile Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 93. Colombia Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 94. Colombia Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 95. Colombia Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 96. Peru Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 97. Peru Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 98. Peru Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 99. Saudi Arabia Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 100. Saudi Arabia Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 101. Saudi Arabia Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 102. Israel Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 103. Israel Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 104. Israel Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 105. UAE Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 106. UAE Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 107. UAE Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 108. Turkey Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 109. Turkey Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 110. Turkey Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 111. Iran Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 112. Iran Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 113. Iran Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 114. Egypt Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 115. Egypt Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 116. Egypt Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 117. Years Considered
Figure 118. Research Process
Figure 119. Key Executives Interviewed
Scope & coverage.
Types
- Carbon-14 Radiosynthesis Services
- Hydrogen-3 Radiosynthesis Services
- Chiral Separation and Salt Formation
- Others
Applications
- Medical Diagnosis and Treatment
- Material Science
- Nuclear Energy
- Others
Companies covered
- Eurofins
- Revvity
- Selcia
- Labcorp
- Pharmaron
- WuXi AppTec
- AM Chemicals
- SEKISUI MEDICAL CO., LTD.
- Nuvisan
- Almac
- Novandi Chemistry
- Alfa Cytology
- Institute of Isotopes Co. Ltd.
- Headway
- ViTrax
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Radiolabeled Compounds Synthesis Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Radiolabeled Compounds Synthesis Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Radiolabeled Compounds Synthesis Service Market Dynamics
- 2.1 Radiolabeled Compounds Synthesis Service Industry Trends
- 2.2 Radiolabeled Compounds Synthesis Service Industry Drivers
- 2.3 Radiolabeled Compounds Synthesis Service Industry Opportunities and Challenges
- 2.4 Radiolabeled Compounds Synthesis Service Industry Restraints
3 Radiolabeled Compounds Synthesis Service Market by Company
- 3.1 Global Radiolabeled Compounds Synthesis Service Company Revenue Ranking in 2025
- 3.2 Global Radiolabeled Compounds Synthesis Service Revenue by Company (2021-2026)
- 3.3 Global Radiolabeled Compounds Synthesis Service Company Ranking (2024-2026)
- 3.4 Global Radiolabeled Compounds Synthesis Service Company Manufacturing Base and Headquarters
- 3.5 Global Radiolabeled Compounds Synthesis Service Company Product Type and Application
- 3.6 Global Radiolabeled Compounds Synthesis Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Radiolabeled Compounds Synthesis Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Radiolabeled Compounds Synthesis Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Radiolabeled Compounds Synthesis Service Market by Type
- 4.1 Radiolabeled Compounds Synthesis Service Type Introduction
- 4.1.1 Carbon-14 Radiosynthesis Services
- 4.1.2 Hydrogen-3 Radiosynthesis Services
- 4.1.3 Chiral Separation and Salt Formation
- 4.1.4 Others
- 4.2 Global Radiolabeled Compounds Synthesis Service Sales Value by Type
- 4.2.1 Global Radiolabeled Compounds Synthesis Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Radiolabeled Compounds Synthesis Service Sales Value by Type (2021-2032)
- 4.2.3 Global Radiolabeled Compounds Synthesis Service Sales Value Share by Type (2021-2032)
5 Radiolabeled Compounds Synthesis Service Market by Application
- 5.1 Radiolabeled Compounds Synthesis Service Application Introduction
- 5.1.1 Medical Diagnosis and Treatment
- 5.1.2 Material Science
- 5.1.3 Nuclear Energy
- 5.1.4 Others
- 5.2 Global Radiolabeled Compounds Synthesis Service Sales Value by Application
- 5.2.1 Global Radiolabeled Compounds Synthesis Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Radiolabeled Compounds Synthesis Service Sales Value by Application (2021-2032)
- 5.2.3 Global Radiolabeled Compounds Synthesis Service Sales Value Share by Application (2021-2032)
6 Radiolabeled Compounds Synthesis Service Regional Value Analysis
- 6.1 Global Radiolabeled Compounds Synthesis Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Radiolabeled Compounds Synthesis Service Sales Value by Region (2021-2032)
- 6.2.1 Global Radiolabeled Compounds Synthesis Service Sales Value by Region: 2021-2026
- 6.2.2 Global Radiolabeled Compounds Synthesis Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Radiolabeled Compounds Synthesis Service Sales Value (2021-2032)
- 6.3.2 North America Radiolabeled Compounds Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Radiolabeled Compounds Synthesis Service Sales Value (2021-2032)
- 6.4.2 Europe Radiolabeled Compounds Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Radiolabeled Compounds Synthesis Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Radiolabeled Compounds Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Radiolabeled Compounds Synthesis Service Sales Value (2021-2032)
- 6.6.2 South America Radiolabeled Compounds Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Radiolabeled Compounds Synthesis Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Radiolabeled Compounds Synthesis Service Sales Value Share by Country, 2025 VS 2032
7 Radiolabeled Compounds Synthesis Service Country-level Value Analysis
- 7.1 Global Radiolabeled Compounds Synthesis Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Radiolabeled Compounds Synthesis Service Sales Value by Country (2021-2032)
- 7.2.1 Global Radiolabeled Compounds Synthesis Service Sales Value by Country (2021-2026)
- 7.2.2 Global Radiolabeled Compounds Synthesis Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Radiolabeled Compounds Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Radiolabeled Compounds Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Radiolabeled Compounds Synthesis Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Eurofins
- 8.1.1 Eurofins Company Information
- 8.1.2 Eurofins Business Overview
- 8.1.3 Eurofins Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Eurofins Radiolabeled Compounds Synthesis Service Product Portfolio
- 8.1.5 Eurofins Recent Developments
- 8.2 Revvity
- 8.2.1 Revvity Company Information
- 8.2.2 Revvity Business Overview
- 8.2.3 Revvity Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Revvity Radiolabeled Compounds Synthesis Service Product Portfolio
- 8.2.5 Revvity Recent Developments
- 8.3 Selcia
- 8.3.1 Selcia Company Information
- 8.3.2 Selcia Business Overview
- 8.3.3 Selcia Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Selcia Radiolabeled Compounds Synthesis Service Product Portfolio
- 8.3.5 Selcia Recent Developments
- 8.4 Labcorp
- 8.4.1 Labcorp Company Information
- 8.4.2 Labcorp Business Overview
- 8.4.3 Labcorp Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Labcorp Radiolabeled Compounds Synthesis Service Product Portfolio
- 8.4.5 Labcorp Recent Developments
- 8.5 Pharmaron
- 8.5.1 Pharmaron Company Information
- 8.5.2 Pharmaron Business Overview
- 8.5.3 Pharmaron Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Pharmaron Radiolabeled Compounds Synthesis Service Product Portfolio
- 8.5.5 Pharmaron Recent Developments
- 8.6 WuXi AppTec
- 8.6.1 WuXi AppTec Company Information
- 8.6.2 WuXi AppTec Business Overview
- 8.6.3 WuXi AppTec Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.6.4 WuXi AppTec Radiolabeled Compounds Synthesis Service Product Portfolio
- 8.6.5 WuXi AppTec Recent Developments
- 8.7 AM Chemicals
- 8.7.1 AM Chemicals Company Information
- 8.7.2 AM Chemicals Business Overview
- 8.7.3 AM Chemicals Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.7.4 AM Chemicals Radiolabeled Compounds Synthesis Service Product Portfolio
- 8.7.5 AM Chemicals Recent Developments
- 8.8 SEKISUI MEDICAL CO., LTD.
- 8.8.1 SEKISUI MEDICAL CO., LTD. Company Information
- 8.8.2 SEKISUI MEDICAL CO., LTD. Business Overview
- 8.8.3 SEKISUI MEDICAL CO., LTD. Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.8.4 SEKISUI MEDICAL CO., LTD. Radiolabeled Compounds Synthesis Service Product Portfolio
- 8.8.5 SEKISUI MEDICAL CO., LTD. Recent Developments
- 8.9 Nuvisan
- 8.9.1 Nuvisan Company Information
- 8.9.2 Nuvisan Business Overview
- 8.9.3 Nuvisan Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Nuvisan Radiolabeled Compounds Synthesis Service Product Portfolio
- 8.9.5 Nuvisan Recent Developments
- 8.10 Almac
- 8.10.1 Almac Company Information
- 8.10.2 Almac Business Overview
- 8.10.3 Almac Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Almac Radiolabeled Compounds Synthesis Service Product Portfolio
- 8.10.5 Almac Recent Developments
- 8.11 Novandi Chemistry
- 8.11.1 Novandi Chemistry Company Information
- 8.11.2 Novandi Chemistry Business Overview
- 8.11.3 Novandi Chemistry Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Novandi Chemistry Radiolabeled Compounds Synthesis Service Product Portfolio
- 8.11.5 Novandi Chemistry Recent Developments
- 8.12 Alfa Cytology
- 8.12.1 Alfa Cytology Company Information
- 8.12.2 Alfa Cytology Business Overview
- 8.12.3 Alfa Cytology Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Alfa Cytology Radiolabeled Compounds Synthesis Service Product Portfolio
- 8.12.5 Alfa Cytology Recent Developments
- 8.13 Institute of Isotopes Co. Ltd.
- 8.13.1 Institute of Isotopes Co. Ltd. Company Information
- 8.13.2 Institute of Isotopes Co. Ltd. Business Overview
- 8.13.3 Institute of Isotopes Co. Ltd. Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Institute of Isotopes Co. Ltd. Radiolabeled Compounds Synthesis Service Product Portfolio
- 8.13.5 Institute of Isotopes Co. Ltd. Recent Developments
- 8.14 Headway
- 8.14.1 Headway Company Information
- 8.14.2 Headway Business Overview
- 8.14.3 Headway Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Headway Radiolabeled Compounds Synthesis Service Product Portfolio
- 8.14.5 Headway Recent Developments
- 8.15 ViTrax
- 8.15.1 ViTrax Company Information
- 8.15.2 ViTrax Business Overview
- 8.15.3 ViTrax Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.15.4 ViTrax Radiolabeled Compounds Synthesis Service Product Portfolio
- 8.15.5 ViTrax Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst